These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 25349172)

  • 61. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y; Liu H; Zhang L; Lv W; Hu X
    Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.
    Swarbrick S; Wragg N; Ghosh S; Stolzing A
    Mol Neurobiol; 2019 Sep; 56(9):6156-6167. PubMed ID: 30734227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Combinatory microRNA serum signatures as classifiers of Parkinson's disease.
    Patil KS; Basak I; Dalen I; Hoedt E; Lange J; Lunde KA; Liu Y; Tysnes OB; Forsgren L; Aarsland D; Neubert TA; Larsen JP; Alves G; Møller SG
    Parkinsonism Relat Disord; 2019 Jul; 64():202-210. PubMed ID: 31003905
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes.
    Yagi Y; Ohkubo T; Kawaji H; Machida A; Miyata H; Goda S; Roy S; Hayashizaki Y; Suzuki H; Yokota T
    Neurosci Lett; 2017 Jan; 636():48-57. PubMed ID: 27780738
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pupil response biomarkers for early detection and monitoring of Alzheimer's disease.
    Frost S; Kanagasingam Y; Sohrabi H; Bourgeat P; Villemagne V; Rowe CC; Macaulay SL; Szoeke C; Ellis KA; Ames D; Masters CL; Rainey-Smith S; Martins RN;
    Curr Alzheimer Res; 2013 Nov; 10(9):931-9. PubMed ID: 24117119
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.
    Carandini T; Arighi A; Sacchi L; Fumagalli GG; Pietroboni AM; Ghezzi L; Colombi A; Scarioni M; Fenoglio C; De Riz MA; Marotta G; Scarpini E; Galimberti D
    Alzheimers Res Ther; 2019 Oct; 11(1):84. PubMed ID: 31615545
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel Blood Biomarkers that Correlate with Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer's Disease.
    Hudd F; Shiel A; Harris M; Bowdler P; McCann B; Tsivos D; Wearn A; Knight M; Kauppinen R; Coulthard E; White P; Conway ME
    J Alzheimers Dis; 2019; 67(3):931-947. PubMed ID: 30689581
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
    Jia LH; Liu YN
    Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
    Burnham SC; Raghavan N; Wilson W; Baker D; Ropacki MT; Novak G; Ames D; Ellis K; Martins RN; Maruff P; Masters CL; Romano G; Rowe CC; Savage G; Macaulay SL; Narayan VA; ;
    J Alzheimers Dis; 2015; 46(4):1079-89. PubMed ID: 26402634
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease.
    Chen JJ; Yang G; Yan QQ; Zhao J; Li S
    Rev Neurosci; 2019 Dec; 31(1):77-87. PubMed ID: 31318699
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
    Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M
    J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Small RNA Deep Sequencing Identifies a Unique miRNA Signature Released in Serum Exosomes in a Mouse Model of Sjögren's Syndrome.
    Kakan SS; Janga SR; Cooperman B; Craig DW; Edman MC; Okamoto CT; Hamm-Alvarez SF
    Front Immunol; 2020; 11():1475. PubMed ID: 32849505
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
    Yu S; Liu YP; Liu HL; Li J; Xiang Y; Liu YH; Jiao SS; Liu L; Wang Y; Fu W
    Mol Neurobiol; 2018 May; 55(5):3999-4008. PubMed ID: 28567666
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Total internal reflection-based single-vesicle in situ quantitative and stoichiometric analysis of tumor-derived exosomal microRNAs for diagnosis and treatment monitoring.
    He D; Wang H; Ho SL; Chan HN; Hai L; He X; Wang K; Li HW
    Theranostics; 2019; 9(15):4494-4507. PubMed ID: 31285775
    [No Abstract]   [Full Text] [Related]  

  • 76. Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
    Wu HZ; Ong KL; Seeher K; Armstrong NJ; Thalamuthu A; Brodaty H; Sachdev P; Mather K
    J Alzheimers Dis; 2016; 49(3):755-66. PubMed ID: 26484928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study.
    Pike KE; Ellis KA; Villemagne VL; Good N; Chételat G; Ames D; Szoeke C; Laws SM; Verdile G; Martins RN; Masters CL; Rowe CC
    Neuropsychologia; 2011 Jul; 49(9):2384-90. PubMed ID: 21529702
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.
    De Meyer G; Shapiro F; Vanderstichele H; Vanmechelen E; Engelborghs S; De Deyn PP; Coart E; Hansson O; Minthon L; Zetterberg H; Blennow K; Shaw L; Trojanowski JQ;
    Arch Neurol; 2010 Aug; 67(8):949-56. PubMed ID: 20697045
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort.
    Pedrini S; Gupta VB; Hone E; Doecke J; O'Bryant S; James I; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Martins RN;
    Sci Rep; 2017 Oct; 7(1):14057. PubMed ID: 29070909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.